Angelica sinensis
Angelica sinensis has been studied in 6 papers since 2016: 1 observational study in people, 4 reviews; 3 in the past year. The newest paper, Sep 25, 2026: “Identification of High-Frequency Drug Combinations for Perimenopausal Syndrome and Associated Conditions via Multilevel Association Rule Mining and Network Pharmacology”.
See all 10 papers on angelica sinensis
- Humans1
- In silico1
Latest
3 papers in 12 monthsNutrients
The Effectiveness of Non-Soy Oral Herbal Supplements for Menopausal Symptoms: A Systematic Review
Systematic review of randomized trialsMenopausal symptoms
Phytomedicine
Association of medicinal plant consumption with all-cause mortality and cognitive impairment in older adult: A large prospective cohort study
Cohort study of 13,918 peopleCognitive impairment
Oxidative Medicine and Cellular Longevity
New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach
ReviewInterventions
Pharmacological Reviews
Botanicals and Their Bioactive Phytochemicals for Women's Health
ReviewInterventions
International Journal of Biological Macromolecules
Angelica sinensis polysaccharide extends lifespan and ameliorates aging-related diseases via insulin and TOR signaling pathways, and antioxidant ability in Drosophila
Experiments in fliesInterventions
Journal of Cellular and Molecular Medicine
Targeting the PI3K/STAT3 axis modulates age-related differences in macrophage phenotype in rats with myocardial infarction
Experiments in animalsInterventions